MORISHITA JINTAN CO.,LTD.
4524 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区玉造一丁目２番４０号
- Website:
- https://www.jintan.co.jp/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Morishita Jintan Co., Ltd., founded in 1893, is a longstanding Japanese company dedicated to enhancing health and well-being. With over a century of experience, the company specializes in developing products that adhere to the highest safety and quality standards. Morishita Jintan's commitment to promoting a healthy lifestyle extends beyond Japan, reaching global markets with innovative solutions designed to improve the quality of life for people everywhere. Through its focus on health and wellness, Morishita Jintan continues to be a trusted name, leveraging decades of expertise to meet the evolving needs of consumers worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-26 06:56 |
Inside Information Statement
臨時報告書
|
Japanese | 23.4 KB | |
| 2025-06-20 08:44 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-06-20 08:41 |
Internal Control over Financial Reporting
内部統制報告書－第88期(2024/04/01－2025/03/31)
|
Japanese | 23.1 KB | |
| 2025-06-20 08:35 |
Annual Report
有価証券報告書－第88期(2024/04/01－2025/03/31)
|
Japanese | 1.1 MB | |
| 2024-11-12 07:15 |
Interim Report
半期報告書－第88期(2024/04/01－2025/03/31)
|
Japanese | 179.7 KB | |
| 2024-11-12 07:13 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-06-27 04:45 |
Inside Information Statement
臨時報告書
|
Japanese | 24.9 KB | |
| 2024-06-26 06:23 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-06-26 06:22 |
Internal Control over Financial Reporting
内部統制報告書－第87期(2023/04/01－2024/03/31)
|
Japanese | 22.2 KB | |
| 2024-06-26 06:21 |
Annual Report
有価証券報告書－第87期(2023/04/01－2024/03/31)
|
Japanese | 1.0 MB | |
| 2024-02-08 05:32 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-02-08 05:31 |
Quarterly Report
四半期報告書－第87期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 162.1 KB | |
| 2023-11-09 05:31 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2023-11-09 05:30 |
Quarterly Report
四半期報告書－第87期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 177.7 KB | |
| 2023-08-09 04:47 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |